J
J.C. Grutters
Researcher at Katholieke Universiteit Leuven
Publications - 31
Citations - 646
J.C. Grutters is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Lung transplantation & Transplantation. The author has an hindex of 14, co-authored 31 publications receiving 594 citations.
Papers
More filters
Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET.
Keijsers Rg,J.C. Grutters,Michiel Thomeer,du Bois Rm,Van Buul Mm,Lavalaye J,van den Bosch Jm,Verzijlbergen Fj +7 more
TL;DR: 18)F-FDG PET is more sensitive than (67)Ga imaging in the assessment of sarcoidosis activity with regard to the mediastinum, hila, lymph nodes and extra pulmonary lesions in general.
Journal Article
18F-FDG PET in sarcoidosis: an observational study in 12 patients with infliximab
Ruth G.M. Keijsers,J. F. Verzijlbergen,D. M. van Diepen,J. M. M. Van Den Bosch,J.C. Grutters +4 more
TL;DR: Changes imaged by 18F-FDG PET during infliximab treatment in sarcoidosis patients correlate with signs of clinical improvement to a considerate extent, which supports the hypothesis that 18F -FDG uptake represents disease activity.
Journal Article
18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
Ruth G.M. Keijsers,E.J. Verzijlbergen,J. M. M. Van Den Bosch,Pieter Zanen,E.M.W. van de Garde,Wim J.G. Oyen,J.C. Grutters +6 more
TL;DR: In sarcoidosis, diffuse parenchymal disease imaged by 18F-FDG PET, predicts a future deterioration of DLCO when untreated, and treatment improves VC, FEV1 and DLCO significantly suggesting that 18f- FDG PET represents the pulmonary improvement that can be achieved.
Journal ArticleDOI
Rituximab in life threatening antisynthetase syndrome.
E. Vandenbroucke,J.C. Grutters,J. Altenburg,W. G. Boersma,E. J. Ter Borg,J. M. M. Van Den Bosch +5 more
TL;DR: This case study reports a patient with severe interstitial pneumonitis, mild polyarthritis and polymyositis, accompanied by the presence of anti-Jo-1 antibodies diagnosed as antisynthetase syndrome, successfully treated with two sequential infusions of rituximab.
Journal Article
Whole Lung Lavage Therapy Of Pulmonary Alveolar ProteINOSis: A Global Survey Of Current Practices And Procedures
Ilaria Campo,M. Luisetti,Matthias Griese,Bruce C. Trapnell,F. Bonella,J.C. Grutters,Koh Nakata,C. H. M. van Moorsel,U Costabel,Vincent Cottin,Toshio Ichiwata,Yoshikazu Inoue,Antonio Braschi,Giacomo Bonizzoni,Giorgio Antonio Iotti,Carmine Tinelli,Giuseppe Rodi +16 more